Point72 Asset Management
SRRA

Point72 Asset Management’s Sierra Oncology, Inc. Common Stock SRRA Stock Holding History

Point72 Asset Management’s Portfolio SRRA Stock Details SRRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-42,656
Closed -$2.92M – 1618
2019
Q1 		$2.92M Hold
42,656
– – 0.01% 654
2018
Q4 		$2.25M Buy
42,656
+2,500
+6% +$160K 0.01% 699
2018
Q3 		$2.73M Hold
40,156
– – 0.01% 716
2018
Q2 		$4.75M Sell
40,156
-9,844
-20% -$988K 0.02% 623
2018
Q1 		$4.14M Buy
50,000
+43,750
+700% +$4.96M 0.02% 617
2017
Q4 		$933K Sell
6,250
-31,250
-83% -$3M ﹤0.01% 809
2017
Q3 		$2.33M Buy
+37,500
New +$2.2M 0.01% 660

Other funds holding SRRA

FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
MP
Mangrove Partners Greenwich, Connecticut $1.24B AUM 41.74% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Point72 Asset Management's SRRA Position: Q2 2019 in Review

Point72 Asset Management sold out of Sierra Oncology, Inc. Common Stock (SRRA) in Q2 2019, closing a stake of 42,656 shares — an estimated $2.92M sold.

Point72 Asset Management first reported a position in SRRA in Q3 2017 and held it in 7 quarters. The position peaked at $4.75M in Q2 2018. 49 funds tracked by Wall St. Rank hold SRRA as of Q2 2019.

  • Point72 Asset Management reported no remaining Sierra Oncology, Inc. Common Stock position as of Q2 2019 after selling out during the quarter.
  • Point72 Asset Management sold 42,656 Sierra Oncology, Inc. Common Stock shares in Q2 2019, an estimated $2.92M.
  • Point72 Asset Management first reported a position in Sierra Oncology, Inc. Common Stock in Q3 2017 and held it in 7 quarters.
  • Point72 Asset Management's Sierra Oncology, Inc. Common Stock position peaked at $4.75M in Q2 2018.
  • 49 funds tracked by Wall St. Rank held Sierra Oncology, Inc. Common Stock as of Q2 2019.

Based on Point72 Asset Management's 13F filing for Q2 2019, filed 14 Aug 2019.